PTeye in Parathyroid Adenoma
Do PTeye Score Correlate With Biochemical Markers in Parathyroid Adenoma?
1 other identifier
observational
50
1 country
1
Brief Summary
Identifying the parathyroids is compulsory for success of parathyroidectomy for parathyroid adenoma. Near-infrared autofluorescence devices have been proposed as useful intraoperative tools for the identification of parathyroid glands. The aim of the present study is to evaluate the correlation of PTeye autofluorescence device with biochemical data of parathyroid adenoma patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 28, 2025
CompletedFirst Submitted
Initial submission to the registry
March 30, 2025
CompletedFirst Posted
Study publicly available on registry
April 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2025
CompletedApril 6, 2025
March 1, 2025
2 months
March 30, 2025
March 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
assess the correlation of PTeye values with biochemical data
Biochemical data included are pre- and postoperative parathyroid hormone, serum calcium, phosphorus and vitamin D levels
intraoperatively and 1st postoperative day
Study Arms (1)
Parathyroid adenoma patients
Patients undergoing surgery for parathyroid adenoma will be enrolled in this study. Parathyroid glands will be identified with the application of autofluorescence device PTeye and the values obtained by the device after parathyroid gland recognition will be registered.
Interventions
Eligibility Criteria
Patients undergoing surgery for parathyroid adenoma
You may qualify if:
- Age \>18 years old
- primary hyperparathyroidism caused by adenoma
- patient's informed consent acquired
You may not qualify if:
- Secondary and tertiary hyperparathyroidism
- Re-operation for adenoma
- Previous neck surgery
- Patient enrolled in another study that may affect the results of this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aristotle Univeristy of Thessaloniki
Thessaloniki, 54636, Greece
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Moysis Moysidis, Dr
Euromedica Kyanos Stavros
- STUDY CHAIR
Chrysa Papadopoulou
Euromedica Kyanos Stavros
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Surgery
Study Record Dates
First Submitted
March 30, 2025
First Posted
April 6, 2025
Study Start
March 28, 2025
Primary Completion
May 30, 2025
Study Completion
May 30, 2025
Last Updated
April 6, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share